Nephrocare Health Services ltd
Bidding Information
- Opens
- Dec 10, 2025
- Closes
- Dec 12, 2025
- Listing Date
- Dec 17, 2025
Company Description
Nephrocare Health Services Ltd IPO
Company Overview
Nephrocare Health Services Ltd is a specialized healthcare provider focused on renal care, dialysis treatments, nephrology consultations, and kidney disease management. The company operates a network of dialysis centers and nephrology clinics that cater to both chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients.
With a mission to deliver high-quality, affordable renal care, Nephrocare integrates advanced dialysis technology, experienced nephrologists, and patient-centric services. The company is expanding its presence in key regions as the demand for dialysis and kidney care rises sharply in India.
Key Highlights
Among the fast-growing renal care and dialysis service providers in India.
Strong presence in chronic disease management focused on kidney health.
Offers advanced dialysis treatments, nephrology consultations, and kidney care programs.
High-quality infrastructure with modern dialysis machines and trained technicians.
Increasing patient footfall driven by rising kidney disease prevalence in India.
Expansion into new cities with scalable and cost-efficient center models.
IPO Objective
Expansion of dialysis centers and nephrology clinics across India.
Upgrading medical equipment and dialysis technology.
Strengthening digital healthcare platforms for remote monitoring and patient management.
Funding working capital requirements for operations.
Repayment or prepayment of debt to improve the financial structure.
General corporate purposes.
Financial Performance
(Awaiting DRHP disclosures; below reflects typical performance trends of renal care providers)
Growing revenue driven by increasing patient volumes and new dialysis centers.
Steady margins supported by recurring treatments and long-term patient relationships.
Strong operational cash flow from regular dialysis cycles.
Controlled capital expenditure due to modular expansion strategy.
Consistent performance backed by rising demand for chronic kidney care services.
Company Strengths
Specialized expertise in nephrology and dialysis treatments.
High patient retention driven by quality of care and clinical outcomes.
Strong leadership with medical and operational experience in renal care.
Cost-efficient center expansion model ensuring faster scalability.
Use of advanced equipment and strong protocols for infection control.
Increasing brand recognition in renal treatment services.
Industry Outlook
India has one of the fastest-growing CKD and ESRD patient populations.
Increased awareness and diagnosis of kidney-related conditions driving demand.
Dialysis services expected to expand due to low transplant availability.
Government support for dialysis under national healthcare schemes boosting access.
Rising lifestyle disorders such as diabetes and hypertension fueling long-term demand.
Strong outlook for specialized renal care centers due to chronic disease patterns.
Check Your Allotment Status
Verify if shares have been allocated to your application
Frequently Asked Questions
Common questions about Nephrocare Health Services ltd IPO
What is the current GMP of Nephrocare Health Services ltd IPO?
The current Grey Market Premium (GMP) of Nephrocare Health Services ltd IPO is ₹465. This indicates an expected listing gain of approximately 1.09% over the issue price of ₹460. GMP reflects unofficial market sentiment and can fluctuate based on demand and market conditions.
When is the allotment date for Nephrocare Health Services ltd IPO?
The allotment date for Nephrocare Health Services ltd IPO is Dec 16, 2025. The IPO listing is scheduled for Dec 17, 2025. You can check your allotment status on the registrar's website once the allotment is finalized.
Is Nephrocare Health Services ltd IPO good for long-term investment?
Nephrocare Health Services ltd IPO shows a current GMP of ₹465 with an expected listing gain of 1.09%. However, investment decisions should be based on your risk profile, company fundamentals, industry outlook, and financial goals. We recommend reviewing the company's DRHP, financial statements, and competitive position. Always consult with a SEBI registered financial advisor before making investment decisions.
What is the issue price and lot size of Nephrocare Health Services ltd IPO?
Nephrocare Health Services ltd IPO has an issue price of ₹460 per share with a lot size of 32 shares. The total issue size is ₹871 crores. This means the minimum investment required is ₹14,720.
Related IPOs You May Like
Explore similar upcoming and active IPOs